A UA research team is trying to solve the mystery behind amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. BIO5's molecular biologist Dr. Daniela Zarnescu is using a catalog of genetic information to sift through a list of drugs that could provide clues to successfully battle the disease.
Related
